Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
5 Patents
#26 in Brisbane, CA
#12,073 in California
#51,644 in US
Pharmix Corporation
Forward Citations = 29
5 inventors:
Brisbane, CA, United States of America
Pharmix Corporation
% Expired Patents = 40.0
Forward Citations = 29
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Jessen Yu (5 out of 7 patents)
Guido Lanza (4 out of 5 patents)
John H Griffin (3 out of 56 patents)
4. Nigel Duffy (1 out of 16 patents)
5. William J Mydlowec (1 out of 4 patents)
5 patents:
1. 7199126 - Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase (2007-04-03),
3. 7183285 - Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase (2007-02-27),
Company Overview
Pharmix Corporation is a leading pharmaceutical company specializing in the development and distribution of innovative medical solutions. With a focus on research and development, we strive to improve the health and well-being of individuals worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmix Corporation. Retrieved from https://idiyas.com/company/pharmix
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]